Author information:
(1)Department of Medical Oncology, Sarcoma Center, West German Cancer Center, 
University Duisburg-Essen, Medical School, Essen, Germany.
(2)DKTK partner site Essen, German Cancer Consortium (DKTK), Heidelberg, 
Germany.
(3)Portland VA Health Care System, Portland, Oregon; Knight Cancer Institute, 
Oregon Health and Science University, Portland, Oregon; and Division of 
Hematology and Medical Oncology, Oregon Health and Science University, Portland, 
Oregon.
(4)Faculty of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, 
Germany.
(5)Drug Discovery Hub Dortmund (DDHD) am Zentrum für Integrierte 
Wirkstoffforschung (ZIW), Dortmund, Germany.
(6)Gerhard-Domagk-Institute of Pathology, University of Münster Medical Center, 
Münster, Germany.
(7)Institute of Pathology, University Medical Center Essen, Essen, Germany.
(8)Department of Visceral Surgery, Sarcoma Center, West German Cancer Center, 
University Duisburg-Essen, Medical School, Essen, Germany.
(9)Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
(10)Blueprint Medicines, Cambridge, Massachusetts.
(11)Department of Medical Oncology, Sarcoma Center, West German Cancer Center, 
University Duisburg-Essen, Medical School, Essen, Germany. 
sebastian.bauer@uk-essen.de.
(#)Contributed equally